Yellow fever vaccine booster doses : recommendations of the Advisory Committee on Immunization Practices, 2015
Published Date:June 19, 2015
Corporate Authors:United States. Advisory Committee on Immunization Practices. ; Centers for Disease Control and Prevention (U.S.) ; National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Vector-Borne Diseases.
Global Health/legislation & Jurisprudence
Practice Guidelines As Topic
Yellow Fever/prevention & Control
Yellow Fever Vaccine/administration & Dosage
Yellow Fever Vaccine/adverse Effects
Yellow Fever Vaccine/immunology
Series:MMWR. Morbidity and mortality weekly report, Vol. 64, no. 23, p. 647-50
Description:On February 26, 2015, the Advisory Committee on Immunization Practices (ACIP) voted that a single primary dose of yellow fever vaccine provides long-lasting protection and is adequate for most travelers. ACIP also approved recommendations for at-risk laboratory personnel and certain travelers to receive additional doses of yellow fever vaccine (Box). The ACIP Japanese Encephalitis and Yellow Fever Vaccines Workgroup evaluated published and unpublished data on yellow fever vaccine immunogenicity and safety. The evidence for benefits and risks associated with yellow fever vaccine booster doses was evaluated using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) framework. This report summarizes the evidence considered by ACIP and provides the updated recommendations for yellow fever vaccine booster doses.
Citation: Centers for Disease Control and Prevention (CDC). Yellow fever vaccine booster doses: recommendations of the Advisory Committee on Immunization Practices, 2015. MMWR Morb Mortal Wkly Rep. 2015 Jun 19;64(23):647-50.
Supporting Files:No Additional Files
You May Also Like: